{"id":2696,"date":"2019-10-07T16:08:26","date_gmt":"2019-10-07T14:08:26","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2696"},"modified":"2024-06-20T12:55:59","modified_gmt":"2024-06-20T10:55:59","slug":"processos-immune-inflamatoris-i-terapia-genica","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-medicina-translacional\/programa-de-gens-malaltia-i-terapia\/processos-immune-inflamatoris-i-terapia-genica\/","title":{"rendered":"Processos Immune-inflamatoris i Ter\u00e0pia G\u00e8nica"},"content":{"rendered":"\n<h1>\n\t\tProcessos immune-inflamatoris i ter\u00e0pia g\u00e8nica\n\t<\/h1>\n<h3>\n\t\tResum\n\t<\/h3>\n\t<p>El grup de recerca en processos immune-inflamatoris i ter\u00e0pia g\u00e9nica realitza recerca translacional amb un enfocament primari sobre les bases moleculars dels processos immune-inflamatoris. El seu objectiu \u00e9s promoure recerca rellevant i d&#8217;excel\u00b7l\u00e8ncia en la inflamaci\u00f3 i proporcionar un entorn \u00f2ptim de formaci\u00f3 per a joves investigadors.<\/p>\n<h2>88<\/h2>\n<h2>Publicacions<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/04\/902_aran.png\" alt=\"902_aran\" itemprop=\"image\" height=\"300\" width=\"600\" title=\"902_aran\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\">L\u00ednies estrat\u00e8giques<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\"><i>Expand<\/i><\/a>\n\t\t\t\t\tIdentificaci\u00f3 i caracteritzaci\u00f3 de noves prote\u00efnes immunomoduladores i avaluaci\u00f3 de la seva rellev\u00e0ncia i potencial terap\u00e8utic en processos autoimmunitaris i trasplantament d&#8217;\u00f2rgans<br \/>\nAn\u00e0lisi de nous biomarcadors diagn\u00f2stics \/ pron\u00f2stics en patologies inflamat\u00f2ries agudes i cr\u00f2niques<br \/>\nEstr\u00e8s oxidatiu en c\u00e8l\u00b7lules epitelials de les vies respirat\u00f2ries. Mecanismes moleculars inflamatoris\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\">Publicacions seleccionades<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>Serrano,I;Luque,A;Ruiz Cerulla,A;Navas,S;Blom,AM;de C\u00f3rdoba,SR;Fern\u00e1ndez,FJ et al, <strong>C4BP(\u00df-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients<\/strong>, Pharmacol. Res., 2023;197106948-106948, doi:10.1016\/j.phrs.2023.106948,<\/li>\n<li>Serrano I, Luque A, Mitjavila F, Blom AM, Rodr\u00edguez de C\u00f3rdoba S, Vega MC, Torras J, Aran JM. <strong>The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory Activity<\/strong>. Front. Immunol. 2022;13883743-883743. doi:10.3389\/fimmu.2022.883743.<\/li>\n<li>Checa J, Martinez Gonzalez I, Maqueda M, Mosquera JL, Aran JM.<strong> Genome-Wide RNAi Screening Identifies Novel Pathways\/Genes Involved in Oxidative Stress and Repurposable Drugs to Preserve Cystic Fibrosis Airway Epithelial Cell Integrity<\/strong>. Antioxidants. 2021;10(12):doi:10.3390\/antiox10121936.<\/li>\n<li>Hueso M, Mall\u00e9n A, Su\u00f1\u00e9 Pou M, Aran JM, Su\u00f1\u00e9 Negre JM, Navarro E. <strong>ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery.<\/strong> Int J Mol Sci. 2021;22(21):doi:10.3390\/ijms222111596.<\/li>\n<li>Guiteras J, Ripoll E, Bolanos N, de Ramon L, Fontova P, Lloberas N, Cruzado JM, Aran JM, Avino A, Eritja R, Goma M, Taco R, Grinyo JM, Torras J. <strong>The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis<\/strong>. Mol. Ther. Nucl. Acids. 2021;24807-821. doi:10.1016\/j.omtn.2021.03.019.<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\">Projectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>FIS23037. <strong>Caracterizaci\u00f3n de Heptammune, un nuevo inmunomodulador biol\u00f3gico para controlar la hiperinflamaci\u00f3n y la inmunidad entrenada desadaptada en enfermedades autoinmunes<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 252.500\u20ac. 2024-2026. PI: ARAN PERRAMON, JOSEP M\u00aa.<\/li>\n<li>21FIS019. <strong>Caracterizaci\u00f3n, potencial diagn\u00f3stico y terape\u00fatico de un nuevo inmunomodulador biol\u00f3gico para el tratamiento de enfermedades autoinmunes<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 171.820\u20ac. 2021-2025. PI: ARAN PERRAMON, JOSEP M\u00aa.<\/li>\n<li>21FIS011. <strong>Desarrollo de un nuevo biol\u00f3gico restaurador de la tolerancia inmunitaria. Aplicaci\u00f3n al tratamiento de la enfermedad inflamatoria intestinal<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 115.500\u20ac. 2021-2023. PI: ARAN PERRAMON, JOSEP M\u00aa.<\/li>\n<li>AGA22021. <strong>PurPose Biotherapeutics: first-in-class metabolic modulators against autoimmune diseases<\/strong>. AGENCIA GESTIO D&#8217;AJUTS UNIV. I RECERCA. Budget: 84.000,06\u20ac. 2022-2024. PI: ARAN PERRAMON, JOSEP M\u00aa.<\/li>\n<li>LCX22001. <strong>PRP6-HO7: a first-in-class biologic immunomodulator against autoimmune diseases<\/strong>. FUNDACI\u00d3 &#8220;LA CAIXA&#8221;. Budget: 70.000\u20ac. 2022-2024. PI: ARAN PERRAMON, JOSEP M\u00aa.<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\">Transfer\u00e8ncia de tecnologia<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\"><i>Expand<\/i><\/a>\n\t\t\t\t\tPAT10- &#8220;Compositions and methods for immunomodulation&#8221;<br \/>\nIP: Josep Maria Aran<br \/>\nOWNERSHIP:100% IDIBELL<br \/>\nREQUEST No.: EP11382240<br \/>\nPRIORITY COUNTRY: European Union<br \/>\nPRIORITY DATE: 15\/07\/11<br \/>\nPCT APPLICATION: PCT\/EP2012\/063932 (16\/07\/12)\nPAT057-Predictive methods of atherosclerosis and stenosis<br \/>\nEP16382025<br \/>\nIP: Josep Maria Aran, Ana Luque\nPAT62- &#8220;C4BP-based compounds for treating immunological diseases&#8221;<br \/>\nOWNERSHIP:100% IDIBELL<br \/>\nREQUEST No.: EP17382187<br \/>\nPRIORITY COUNTRY: European Union<br \/>\nPRIORITY DATE: 06\/04\/17<br \/>\nPCT APPLICATION: PCT\/EP2018\/058773 (06\/07\/18)\nPAT76- &#8220;Compounds for immunomodulation&#8221;<br \/>\nINVENTORS: Aran, J.M., Luque, A., Serrano, I.<br \/>\nOWNERSHIP:100% IDIBELL<br \/>\nREQUEST No.: EP19382910<br \/>\nPRIORITY COUNTRY: European Union<br \/>\nPRIORITY DATE: 17\/10\/19\nLicense: ISR-TEST: Test r\u00e0pid pel diagn\u00f2stic del risc d&#8217;ICTUS<br \/>\nPI: Dr. Josep Maria Aran\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/10\/aran-perramon-jose-maria-150x150.jpg\" alt=\"Aran Perramon, Jose Maria\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"aran-perramon-jose-maria\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tAran Perramon, Jose Maria\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:vmoreno@idibell.cat\" title=\"jaran@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tjaran@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/10\/aran-perramon-jose-maria-150x150.jpg\" alt=\"Aran Perramon, Jose Maria\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"aran-perramon-jose-maria\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tAran Perramon, Jose Maria\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:vmoreno@idibell.cat\" title=\"jaran@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tjaran@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-0\" data-index=\"0\" aria-selected=\"true\" aria-controls=\"fl-tabs--panel-0\" aria-expanded=\"true\" role=\"tab\" tabindex=\"0\">\t\t\t\tCaps de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-1\" data-index=\"1\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-1\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadors\/es postdoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\tCaps de grup\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Aran Perramon, Jose Maria<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es postdoctorals\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Luque Gomez, Ana<\/li>\n<li>Serrano Santacruz, Inmaculada<\/li>\n<\/ul>\n<h2>\n\t\tNot\u00edcies relacionades\n\t<\/h2>\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24373\" content=\"Descriuen un nou f\u00e0rmac biol\u00f2gic capa\u00e7 de restablir l'home\u00f2stasi del sistema immune\" \/><meta itemprop=\"datePublished\" content=\"2023-10-31\" \/><meta itemprop=\"dateModified\" content=\"2023-10-31\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/10\/thumbnail_IMG_4570.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/10\/descriuen-un-nou-farmac-biologic-capac-de-restablir-lhomeostasi-del-sistema-immune\/\" title=\"Descriuen un nou f\u00e0rmac biol\u00f2gic capa\u00e7 de restablir l'home\u00f2stasi del sistema immune\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/10\/descriuen-un-nou-farmac-biologic-capac-de-restablir-lhomeostasi-del-sistema-immune\/\" title=\"Descriuen un nou f\u00e0rmac biol\u00f2gic capa\u00e7 de restablir l'home\u00f2stasi del sistema immune\">Descriuen un nou f\u00e0rmac biol\u00f2gic capa\u00e7 de restablir l&#8217;home\u00f2stasi del sistema immune<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t31\/10\/2023\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/22607\" content=\"La fundaci\u00f3 hna col\u00b7labora en el desenvolupament d&#8217;un nou f\u00e0rmac contra les malalties inflamat\u00f2ries intestinals\" \/><meta itemprop=\"datePublished\" content=\"2022-12-19\" \/><meta itemprop=\"dateModified\" content=\"2022-12-16\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/12\/NP30-JM-Aran_Proj-HNA-Imatge-noti.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2022\/12\/la-fundacio-hna-collabora-en-el-desenvolupament-dun-nou-farmac-contra-les-malalties-inflamatories-intestinals\/\" title=\"La fundaci\u00f3 hna col\u00b7labora en el desenvolupament d&#8217;un nou f\u00e0rmac contra les malalties inflamat\u00f2ries intestinals\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2022\/12\/la-fundacio-hna-collabora-en-el-desenvolupament-dun-nou-farmac-contra-les-malalties-inflamatories-intestinals\/\" title=\"La fundaci\u00f3 hna col\u00b7labora en el desenvolupament d&#8217;un nou f\u00e0rmac contra les malalties inflamat\u00f2ries intestinals\">La fundaci\u00f3 hna col\u00b7labora en el desenvolupament d&#8217;un nou f\u00e0rmac contra les malalties inflamat\u00f2ries intestinals<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t19\/12\/2022\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/21886\" content=\"Un projecte de Josep Maria Aran rep l'impuls de les ajudes CaixaResearch Validate\" \/><meta itemprop=\"datePublished\" content=\"2022-07-12\" \/><meta itemprop=\"dateModified\" content=\"2022-07-12\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/07\/NO75-La-Caixa-Validate_JM-Aran-Imatge.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2022\/07\/un-projecte-de-josep-maria-aran-rep-limpuls-de-les-ajudes-caixaresearch-validate\/\" title=\"Un projecte de Josep Maria Aran rep l'impuls de les ajudes CaixaResearch Validate\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2022\/07\/un-projecte-de-josep-maria-aran-rep-limpuls-de-les-ajudes-caixaresearch-validate\/\" title=\"Un projecte de Josep Maria Aran rep l'impuls de les ajudes CaixaResearch Validate\">Un projecte de Josep Maria Aran rep l&#8217;impuls de les ajudes CaixaResearch Validate<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t12\/07\/2022\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/21348\" content=\"Presenten una nova prote\u00efna recombinant que reverteix l&#8217;estat proinflamatori de c\u00e8l\u00b7lules de pacients amb lupus\" \/><meta itemprop=\"datePublished\" content=\"2022-05-10\" \/><meta itemprop=\"dateModified\" content=\"2022-05-10\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/05\/NO47-JM-Aran_Frontiers-Immunol-Imatge.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2022\/05\/presenten-una-nova-proteina-recombinant-que-reverteix-lestat-proinflamatori-de-cellules-de-pacients-amb-lupus\/\" title=\"Presenten una nova prote\u00efna recombinant que reverteix l&#8217;estat proinflamatori de c\u00e8l\u00b7lules de pacients amb lupus\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2022\/05\/presenten-una-nova-proteina-recombinant-que-reverteix-lestat-proinflamatori-de-cellules-de-pacients-amb-lupus\/\" title=\"Presenten una nova prote\u00efna recombinant que reverteix l&#8217;estat proinflamatori de c\u00e8l\u00b7lules de pacients amb lupus\">Presenten una nova prote\u00efna recombinant que reverteix l&#8217;estat proinflamatori de c\u00e8l\u00b7lules de pacients amb lupus<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t10\/05\/2022\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/20048\" content=\"S'obren noves vies en el tractament de la fibrosi qu\u00edstica\" \/><meta itemprop=\"datePublished\" content=\"2021-12-29\" \/><meta itemprop=\"dateModified\" content=\"2021-12-23\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/12\/NO119-JM-Aran_Antioxidants-Imatge.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/12\/sobren-noves-vies-en-el-tractament-de-la-fibrosi-quistica\/\" title=\"S'obren noves vies en el tractament de la fibrosi qu\u00edstica\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/12\/sobren-noves-vies-en-el-tractament-de-la-fibrosi-quistica\/\" title=\"S'obren noves vies en el tractament de la fibrosi qu\u00edstica\">S&#8217;obren noves vies en el tractament de la fibrosi qu\u00edstica<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t29\/12\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/17288\" content=\"IDIBELL celebra el Kickoff Meeting sobre els Projectes d'Investigaci\u00f3 en Salut concedits per l'ISCIII\" \/><meta itemprop=\"datePublished\" content=\"2021-04-20\" \/><meta itemprop=\"dateModified\" content=\"2022-01-11\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/04\/MicrosoftTeams-image.jpg\" \/><meta itemprop=\"width\" content=\"1867\" \/><meta itemprop=\"height\" content=\"1161\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/04\/idibell-celebra-el-kickoff-meeting-sobre-els-projectes-dinvestigacio-en-salut-concedits-per-lisciii\/\" title=\"IDIBELL celebra el Kickoff Meeting sobre els Projectes d'Investigaci\u00f3 en Salut concedits per l'ISCIII\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2021\/04\/idibell-celebra-el-kickoff-meeting-sobre-els-projectes-dinvestigacio-en-salut-concedits-per-lisciii\/\" title=\"IDIBELL celebra el Kickoff Meeting sobre els Projectes d'Investigaci\u00f3 en Salut concedits per l'ISCIII\">IDIBELL celebra el Kickoff Meeting sobre els Projectes d&#8217;Investigaci\u00f3 en Salut concedits per l&#8217;ISCIII<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t20\/04\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/15215\" content=\"Finan\u00e7ament per a estudiar nous f\u00e0rmacs contra les malalties autoimmunit\u00e0ries\" \/><meta itemprop=\"datePublished\" content=\"2020-10-29\" \/><meta itemprop=\"dateModified\" content=\"2020-10-29\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/10\/Imatge-1.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2020\/10\/financament-per-a-estudiar-nous-farmacs-contra-les-malalties-autoimmunitaries\/\" title=\"Finan\u00e7ament per a estudiar nous f\u00e0rmacs contra les malalties autoimmunit\u00e0ries\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2020\/10\/financament-per-a-estudiar-nous-farmacs-contra-les-malalties-autoimmunitaries\/\" title=\"Finan\u00e7ament per a estudiar nous f\u00e0rmacs contra les malalties autoimmunit\u00e0ries\">Finan\u00e7ament per a estudiar nous f\u00e0rmacs contra les malalties autoimmunit\u00e0ries<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t29\/10\/2020\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/7350\" content=\"Investigadors de l&#8217;IDIBELL descobreixen que una mol\u00e8cula de la sang \u00e9s efectiva contra la malaltia autoimmune de rony\u00f3\" \/><meta itemprop=\"datePublished\" content=\"2020-02-03\" \/><meta itemprop=\"dateModified\" content=\"2020-05-15\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/05\/np48_-_jm_aran_nefritis_lupica_-_image_team_1.jpg\" \/><meta itemprop=\"width\" content=\"1280\" \/><meta itemprop=\"height\" content=\"960\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2020\/02\/investigadors-de-lidibell-descobreixen-que-una-molecula-de-la-sang-es-efectiva-contra-la-malaltia-autoimmune-de-ronyo\/\" title=\"Investigadors de l&#8217;IDIBELL descobreixen que una mol\u00e8cula de la sang \u00e9s efectiva contra la malaltia autoimmune de rony\u00f3\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2020\/02\/investigadors-de-lidibell-descobreixen-que-una-molecula-de-la-sang-es-efectiva-contra-la-malaltia-autoimmune-de-ronyo\/\" title=\"Investigadors de l&#8217;IDIBELL descobreixen que una mol\u00e8cula de la sang \u00e9s efectiva contra la malaltia autoimmune de rony\u00f3\">Investigadors de l&#8217;IDIBELL descobreixen que una mol\u00e8cula de la sang \u00e9s efectiva contra la malaltia autoimmune de rony\u00f3<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t03\/02\/2020\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/7511\" content=\"Paperdrop Diagnostics, IDIBELL i  M\u00fatuaTerrassa col\u00b7laboren en el disseny del primer test r\u00e0pid per preveure l'ictus isqu\u00e8mic\" \/><meta itemprop=\"datePublished\" content=\"2019-02-22\" \/><meta itemprop=\"dateModified\" content=\"2020-05-13\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/04\/img_grup_paperdrop-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1920\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2019\/02\/paperdrop-diagnostics-idibell-i-mutuaterrassa-col%c2%b7laboren-en-el-disseny-del-primer-test-rapid-per-preveure-lictus-isquemic\/\" title=\"Paperdrop Diagnostics, IDIBELL i  M\u00fatuaTerrassa col\u00b7laboren en el disseny del primer test r\u00e0pid per preveure l'ictus isqu\u00e8mic\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2019\/02\/paperdrop-diagnostics-idibell-i-mutuaterrassa-col%c2%b7laboren-en-el-disseny-del-primer-test-rapid-per-preveure-lictus-isquemic\/\" title=\"Paperdrop Diagnostics, IDIBELL i  M\u00fatuaTerrassa col\u00b7laboren en el disseny del primer test r\u00e0pid per preveure l'ictus isqu\u00e8mic\">Paperdrop Diagnostics, IDIBELL i  M\u00fatuaTerrassa col\u00b7laboren en el disseny del primer test r\u00e0pid per preveure l&#8217;ictus isqu\u00e8mic<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t22\/02\/2019\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/7877\" content=\"\u00c8xit de la 1a Nit Solid\u00e0ria amb la Recerca per la Fibrosi Qu\u00edstica\" \/><meta itemprop=\"datePublished\" content=\"2016-12-07\" \/><meta itemprop=\"dateModified\" content=\"2020-05-13\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/05\/20161201_1aNitSolidaria1_0-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1594\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2016\/12\/exit-de-la-1a-nit-solidaria-amb-la-recerca-per-la-fibrosi-quistica\/\" title=\"\u00c8xit de la 1a Nit Solid\u00e0ria amb la Recerca per la Fibrosi Qu\u00edstica\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2016\/12\/exit-de-la-1a-nit-solidaria-amb-la-recerca-per-la-fibrosi-quistica\/\" title=\"\u00c8xit de la 1a Nit Solid\u00e0ria amb la Recerca per la Fibrosi Qu\u00edstica\">\u00c8xit de la 1a Nit Solid\u00e0ria amb la Recerca per la Fibrosi Qu\u00edstica<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t07\/12\/2016\t\t\t\t\t\t\t\n\t\t<!-- .pp-content-posts -->\n\n","protected":false},"excerpt":{"rendered":"<p>Processos immune-inflamatoris i ter\u00e0pia g\u00e8nica Resum El grup de recerca en processos immune-inflamatoris i ter\u00e0pia g\u00e9nica realitza recerca translacional amb un enfocament primari sobre les bases moleculars dels processos immune-inflamatoris. El seu objectiu \u00e9s promoure recerca rellevant i d&#8217;excel\u00b7l\u00e8ncia en la inflamaci\u00f3 i proporcionar un entorn \u00f2ptim de formaci\u00f3 per a joves investigadors. 88 Publicacions [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":552,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-2696","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2024-12-29 04:16:54","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=2696"}],"version-history":[{"count":8,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2696\/revisions"}],"predecessor-version":[{"id":26037,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2696\/revisions\/26037"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/552"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=2696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}